# DMIIR (Drugs Made in America Acquisition Ii Corp.) - SEC EDGAR Financial Statements

> Drugs Made in America Acquisition Ii Corp. reported $518.7M in total assets and net income of $17.68M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/DMIIR
- Markdown: https://convexityos.com/fundamentals/DMIIR.md
- SEC CIK: 0002040475
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:34 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002040475&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$557K | Operating profit |
| Net Income | FY 2025 | $17.68M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Total Operating Expenses | $488K |
| **Operating Income** | -$488K |
| Interest Income | $4.93M |
| **Net Income** | $4.19M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Total Operating Expenses | $77K | $112K | $132K | $235K | $156K | $38K | $59K |
| **Operating Income** | -$77K | -$112K | -$132K | -$235K | -$156K | -$38K | -$59K |
| Interest Income | $4.70M | $4.51M | $4.44M | -- | $109K | -- | -- |
| **Net Income** | $4.62M | $4.40M | $4.34M | $4.33M | -$46K | -$38K | -$59K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $223 | $17K |
| **Cash & Short-Term Investments** | $223 | $17K |
| **Total Current Assets** | $26K | $60K |
| **Total Non-Current Assets** | $504.9M | $78K |
| **Total Assets** | $505.0M | $138K |
| Accounts Payable | $99K | -- |
| Other Current Liabilities | $0 | -- |
| **Total Current Liabilities** | $301K | $255K |
| **Total Non-Current Liabilities** | $17.50M | $0 |
| **Total Liabilities** | $17.80M | $255K |
| Common Stock | $1.4K | $1.4K |
| Retained Earnings | -$17.78M | -$152K |
| **Total Stockholders' Equity** | -$17.77M | -$117K |
| Total Equity | -$17.77M | -$117K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $175K | $348K | $223 | $315K | $17K |
| **Cash & Short-Term Investments** | -- | $175K | $348K | $223 | $315K | $17K |
| **Total Current Assets** | $140K | $218K | $352K | $26K | $896K | $60K |
| **Total Non-Current Assets** | $518.6M | $513.9M | $509.4M | $504.9M | $500.1M | $78K |
| **Total Assets** | $518.7M | $514.1M | $509.7M | $505.0M | $501.0M | $138K |
| Accounts Payable | $79K | $12K | $49K | $99K | $4.6K | -- |
| Short-Term Debt | -- | $450K | $450K | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $0 | $554K | -- |
| **Total Current Liabilities** | $643K | $645K | $666K | $301K | $677K | $255K |
| **Total Non-Current Liabilities** | $17.50M | $17.50M | $17.50M | $17.50M | $17.50M | $0 |
| **Total Liabilities** | $18.14M | $18.14M | $18.17M | $17.80M | $18.18M | $255K |
| **Total Debt (incl. Leases)** | -- | $450K | $450K | -- | -- | -- |
| Common Stock | $1.4K | $1.4K | $1.4K | $1.4K | $1.6K | $1.4K |
| Retained Earnings | -$18.01M | -$17.93M | -$17.82M | -$17.78M | -$17.28M | -$152K |
| **Total Stockholders' Equity** | -$18.00M | -$17.93M | -$17.81M | -$17.77M | -$17.28M | -$117K |
| Total Equity | -$18.00M | -$17.93M | -$17.81M | -$17.77M | -$17.28M | -$117K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Net Income | $4.19M |
| Change in Payables | $99K |
| **Operating Cash Flow** | -$1.02M |
| **Investing Cash Flow** | -$500.0M |
| **Financing Cash Flow** | $501.0M |
| **Net Change in Cash** | -$17K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $4.62M | $4.40M | $4.34M | $4.33M | -$46K | -$38K | -$59K |
| Change in Payables | -- | -$22K | -$22K | $95K | $2.4K | -$9.1K | $11K |
| **Operating Cash Flow** | -$57K | -$173K | -$103K | -$315K | -$691K | -$2.6K | -$10K |
| **Financing Cash Flow** | $0 | $0 | $450K | -- | -- | -- | -- |
| **Net Change in Cash** | -$57K | -$173K | $347K | -$315K | $311K | -$2.6K | -$10K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Return on Assets (ROA) | 0.8% |
| Current Ratio | 0.09x |
| Quick Ratio | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | 3.4% | 2.5% | 1.7% | 0.8% | -- | -- | -- |
| Current Ratio | 0.22x | 0.34x | 0.53x | 0.09x | 1.32x | -- | -- |
| Quick Ratio | -- | 0.27x | 0.52x | 0.00x | 0.47x | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
